Clinical Trial Update: Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial exploring targets and biomarkers involved in allergic responses in subjects with allergic rhinitis; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Snippet

Sponsor: GlaxoSmithKline | Conditions: Allergic Rhinitis | Phase 1 | Status: COMPLETED